DeNino, Mark J.

Managing Director

Guy Hoffman

Partner

Robert Keith

Managing Director, Co-Founder and CEO

Janet L. Stott

CFO

116 past transactions

Donuts

Series C in 2015
Donuts Inc is the registry of next generation domain names. With nearly 200 top-level domains, and millions of registrants, Donuts offers a wide variety of clear and meaningful names that represent your identity online in the best possible way. Whether looking for business identifiers (.ltd), navigation (.support), vertical market specifics (.builders) or broad-based generics (.world), their portfolio offers unequaled precision and differentiation. Using their industry-first DPML product, they also work with a large majority of the top global brands to protect their trademarks online. With office locations in Seattle, Washington DC, Los Angeles, London and Hong Kong, they sell their products through the world's leading registrars and resellers, including Go Daddy, Alibaba and 1and1.

iSpot.tv

Series A in 2013
iSpot.tv helps advertisers measure the brand and business impact of TV and streaming advertising, from concept to airing to conversion. Fast, accurate, and actionable measurement and attribution solutions enable advertisers to assess creative effectiveness, enhance media plans and attribute advertising results for cross-platform campaigns, all while benchmarking against competitors and historical norms. Unlike legacy and ad hoc solutions, iSpot is purpose-built to measure the performance of every ad on television with digital-like precision and granularity in real-time. With always-on performance insights unified across linear and streaming TV, advertisers can take quick and confident action to consistently drive business results. The company was founded in 2012 and is headquartered in Bellevue, Washington.

Pivotal Systems

Venture Round in 2012
Pivotal Systems provides a gas flow monitoring and control technology platform for the global semiconductor industry. The company’s proprietary hardware and software utilizes advanced machine learning to enable preventative diagnostic capability resulting in an order of magnitude increase in fab productivity and capital efficiency for existing and future technology nodes.

Global Education Learning

Venture Round in 2012
GEL’s vision is to influence and give young Chinese children the world’s best educational products and services. Our goal is to not only help them succeed in subjects such as English, Chinese, math, and science but importantly provide tools that will promote EQ, creativity and strong values. GEL’s, subsididary, Yaolan, operates one of the most trusted and influential sites focused on parents of young kids between 0-6. Yaolan has a nationwide brand with a strong and dedicated following. GEL will win because it integrates a unique and highly defensible multi-pronged distribution network throughout China – including first, second, and third tier cities. This is critical to differentiating GEL. GEL will succeed because it will build a strong and trusted nationwide brand. Phase 1 of GEL’s strategy is to form its robust distribution engine with Yaolan as our online foundation. We will complement Yaolan with off-line distribution which includes learning centers, physical stores (to market our brand) In phase 2, we will invest in world-class content and technology from China, the United States, and the rest of the world that we can put through our channels. Because of this distribution network and US management practices, we are confident that we will be the go-to “China” partner for any early education product and services attempting to enter China. Internationally, GEL’s focus will be on acquiring and investing in companies with world-class content and technology. GEL’s management and advisory board has one of the best track records of creating and investing in companies focused on the for-profit education space. Our proprietary deal flow and relationships enables us to be the first to see and evaluate the latest and most interesting opportunities in the space. When coupled with a highly valuable distribution engine into the world’s largest market, GEL will be to go-to investor and partner for both new and well-established players in the for-profit education space.

Moonshoot

Venture Round in 2012
Moonshoot's mission is to spark English language learning in children everywhere. It has launched its service in Japan in April 2010. Moonshoot makes learning English fun and exciting for children by using online games. Moonshoot's first release starts with a concrete goal of helping child build a vocabulary of 600 words, 200 phrases, that will enable them to read up to 50 classic children's books.

Noble Biomaterials

Series B in 2012
Noble Biomaterials is a global leader in antimicrobial and conductivity solutions for soft surface applications. They supply medical components to the US military, and a US EPA–registered antimicrobial manufacturer.

Donuts

Series A in 2012
Donuts Inc is the registry of next generation domain names. With nearly 200 top-level domains, and millions of registrants, Donuts offers a wide variety of clear and meaningful names that represent your identity online in the best possible way. Whether looking for business identifiers (.ltd), navigation (.support), vertical market specifics (.builders) or broad-based generics (.world), their portfolio offers unequaled precision and differentiation. Using their industry-first DPML product, they also work with a large majority of the top global brands to protect their trademarks online. With office locations in Seattle, Washington DC, Los Angeles, London and Hong Kong, they sell their products through the world's leading registrars and resellers, including Go Daddy, Alibaba and 1and1.

BostInno

Seed Round in 2011
BostInno is a Boston-based online news portal that delivers news related to business, technology, education, and sports. It is operated by [Streetwise Media](http://www.crunchbase.com/organization/streetwise-media), a digital media and events company. Its editorial staff consists of fast, edgy, and opinionated members, and it is an open community publishing platform. BostInno was founded in 2001 and is based in Boston, M.A.

Skycross

Series E in 2011
[Skycross](http://www.skycross.com) is a global wireless antenna solutions company. They serve a range of market segments including handsets, data cards, USB dongles, laptops, access points, mobile personal entertainment devices, and more.

AirWalk Communications

Series B in 2011
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.

Celator Pharmaceuticals

Series D in 2010
Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

Velsys Limited

Venture Round in 2010
Velsys Limited is a global independent financial technology services provider that delivers FX trading solutions, which enable banks, brokers, and financial institutions to deliver value to their customers. It is capable of supporting large and small financial institutions on a global basis. The company has also developed a core set of FX software applications that have flexible deployment options, including a fully hosted option with a global footprint and have been designed to appeal to mid- and smaller-sized regional banks. Launched in 1996, Velsys Limited is headquartered in Adelaide, Australia with an additional office in London, United Kingdom.

Moonshoot

Venture Round in 2010
Moonshoot's mission is to spark English language learning in children everywhere. It has launched its service in Japan in April 2010. Moonshoot makes learning English fun and exciting for children by using online games. Moonshoot's first release starts with a concrete goal of helping child build a vocabulary of 600 words, 200 phrases, that will enable them to read up to 50 classic children's books.

Translarity

Series B in 2009
Translarity is an innovator in the semiconductor wafer test industry, focused on the advanced probe card market. Headquartered in Silicon Valley, Translarity brings a disruptive change to the world of semiconductor test by offering a full-wafer test with low cost, high performance, and short cycle time. Translarity acquired BucklingBeam in 2017 to expand its offerings and deliver a full suite of probe card solutions, including full probe cards and vertical probe head solutions. Combined with the company’s advanced Space Translator™ space transformer technology, the company addresses the rapid state of acceleration in probe technologies. Translarity’s proven management team, backed by strong financial investors, recruited a dynamic team of top industry talent to address the unmet challenges in building the Wafer Translator™ technology. In creating the Translarity solution, the team developed a fertile innovation pipeline and a strong IP portfolio, with more than 45 patents already issued and more than 50 filed.

Finite Carbon

Series A in 2009
Finite Carbon provides landowners with an all-in-one carbon offset monitoring system. Finite Carbon assumes all risks and expenses associated with project issuance and manages all development phases in-house. Finite Carbon works with clients and trains them to ensure that their carbon project is fully integrated with their forest ownership goals and timber operations.

Celator Pharmaceuticals

Series C in 2008
Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

ScaleMP

Series D in 2008
ScaleMP™ is the leader in virtualization for high-end computing, providing higher performance and lower Total Cost of Ownership (TCO). The innovative Versatile SMP™ (vSMP) architecture aggregates multiple x86 systems into a single virtual x86 system, delivering an industry-standard, high-end symmetric multiprocessor (SMP) computer. Using software to replace custom hardware and components, ScaleMP offers a new, revolutionary computing paradigm.

Kleer

Series B in 2008
Kleer combines an advanced, cloud-based platform with dedicated and personalized support to ensure your practice has everything you need to easily and quickly design, implement, and professionally manage a successful membership plan. Kleer has implemented membership plans for 7,000+ dentists and has a team dedicated to your success.

AirWalk Communications

Series B in 2008
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.

Sopherion Therapeutics

Venture Round in 2008
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company headquartered in Princeton, New Jersey with offices in Cheshire, Connecticut, Estero, Florida and an operating subsidiary, Sopherion Therapeutics Canada, in Toronto, Canada. Sopherion Therapeutics LLC is a specialty biopharmaceutical company with an exclusive licensing agreement with Zeneus Pharma Ltd., now Cephalon, Inc., for the commercialization of Myocet™ (a liposome-encapsulated doxorubicin-citrate complex) in the United States and Canada. Sopherion’s current business focus is the execution of a Phase III, global, randomized, registration trial for first line therapy of invasive, metastatic breast cancer and the development and commercialization of Sopherion’s lead agent, Myocet™. Myocet is being investigated in an FDA agreed upon registration trial in combination with two other drugs, Herceptin® (Trastuzumab) and Taxol (Paclitaxel) vs. Herceptin® and Taxol alone, the current standard of care for first line HER-2-overexpressing metastatic breast cancer. Myocet™, a liposome-encapsulated doxorubicin with reduced cardiotoxicity, is a nanotechnology product that localizes into tumor vasculature and in contrast to parental doxorubicin avoids homing to the heart. This 363 patient global trial in twelve countries has as of 03/06/09 been fully recruited. Unblinding is anticipated by the summer of 2010 with NDA submission for full approval following within 6 months. Myocet® is already a registered drug in Canada, where Sopherion has commercial rights and in Europe where Cephalon has commercial rights for use in first line metastatic breast cancer in combination with cyclophosphamide.; Their Phase III trial is based on a Phase II trial, supported by Roche, which gave a 96% response rate and two and a half year median progression free survival for patients with metastatic breast cancer.

NorthStar Systems International

Venture Round in 2007
NorthStar Systems International, Inc. provides wealth management software solutions to financial services institutions primarily in the United States. Its solutions include NorthStar Client Acquisition Solution that allows asset managers and wealth management firms to provide their advisors the client profiling and communication tools; NorthStar Client Reporting Solution, which enables wealth managers to offer reports and reviews for clients; NorthStar Compliance Solution that offers compliance systems' functionalities; and NorthStar Product Catalog Solution, which allows wealth managers to build customized portfolios. The company also offers client hierarchy, enterprise product hub, planning and portfolio construction, data, and platform services; and professional and technical support services. Its solutions allow users to automate and streamline their wealth management workflows. The company serves financial advisors, wealth managers, banks, trusts, broker-dealers, multi-family offices, and service providers. It delivers its solutions on-premise or on-demand. The company was founded in 2001 and is based in San Francisco, California.

Optichron

Venture Round in 2007
Optichron®, Inc., a leader in nonlinear signal processing technology, designs and manufactures integrated circuits that enable significant improvements in system-level cost:performance for communications applications. Founded in January 2003, Optichron focuses on a significant technology challenge - a solution to the performance bottleneck caused by nonlinear distortion, a long-standing engineering barrier in many industries relying on signal processing technologies. Industry experts have long recognized nonlinear distortion as the principal roadblock to tapping the optimum performance potential in communications, data conversion and other signal processing applications because previous engineering approaches were inefficient, inadequate, cumbersome or expensive. There team has developed a proprietary mathematical approach to solving nonlinear distortion, from which we have derived a robust integrated circuit architecture that is the core of our linearization products. By efficiently eliminating all types of nonlinear distortion, our linearization technology significantly improves the parameters for overall system design and, through reduced component count and more efficient operation, lowers cost and power consumption. We embed our linearization technology in our practical, high-performance linearization products for applications such as wireless communications, software-defined radio, medical imaging, satellite communications, radar, infrared imaging, and test and measurement instrumentation.

Celator Pharmaceuticals

Series C in 2007
Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

QuatRx Pharmaceuticals

Series E in 2007
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics.QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

NetEffect Sytems

Series C in 2007
NetEffect has offered dependable cybersecurity and IT services to companies in Las Vegas.
CICLON Semiconductor Device Corporation (pronounced see-clone) is a leader in the design, development, and sale of high-frequency, high-efficiency RF LDMOS and power MOSFET semiconductor solutions for high-performance information technology applications. The company was founded in 2004 and is based in Bethlehem, Pennsylvania. As of February 11, 2009, CICLON Semiconductor Device Corp. operates as a subsidiary of Texas Instruments Inc.

Atrenta

Venture Round in 2006
Atrenta’s SpyGlass Predictive Analysis software platform significantly improves design efficiency for the world’s leading semiconductor and consumer electronics companies. Patented solutions provide early design insight into the demanding performance, power and area requirements of the complex system on chips (SoCs) fueling today’s consumer electronics revolution. More than two hundred companies and thousands of design engineers worldwide rely on SpyGlass to reduce risk and cost before traditional EDA tools are deployed. SpyGlass functions like an interactive guidance system for design engineers and managers, finding the fastest and least expensive path to implementation for complex SoCs. SpyGlass from Atrenta: Insight. Efficiency. Confidence.

AirWalk Communications

Series B in 2006
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.

VeriWave

Series C in 2006
Testing with VeriWave ensures maximum performance for mobile networks, devices and applications in the real world. From development through deployment and beyond, VeriWave helps leading manufacturers, service providers and users measure, analyze and improve speed, quality, interoperability, compliance and other pivotal aspects of mobile performance.

JAM Technologies

Series B in 2006
JAM Technologies operates as a mixed signal semiconductor company. It designs audio system interface chips for audio-centric consumer electronics, including flat panel TVs, computers, and portable media players. JamTech offers True Fidelity sub-ranging pulse width modulation digital amplifiers. It sells its ICs through direct sales force and distributors. The company was founded in 1999 and is headquartered in Austin, Texas, with an additional office in Singapore.

ClariFI

Venture Round in 2006
ClariFI, Inc. provides software and services focusing on quantitative investment management and research. It offers ModelStation, a solution with data management, factor backtesting, model construction, strategy simulation, portfolio optimization, risk and performance attribution, production scheduling, and enterprise adoption modules. The company's services include data integration and management, workflow creation, statistical/computational algorithms, risk model development, forecast model development, and strategy script development. It also provides integration services to in-house data warehouses or custom feeds. The company was founded in 1999 and is headquartered in New York, New York with additional offices in Boston, Massachusetts; El Segundo, California; and London, United Kingdom. As of May 15, 2007, ClariFI, Inc. operates as a subsidiary of Capital IQ, Inc.

Skycross

Series C in 2006
[Skycross](http://www.skycross.com) is a global wireless antenna solutions company. They serve a range of market segments including handsets, data cards, USB dongles, laptops, access points, mobile personal entertainment devices, and more.

Sonics

Series D in 2005
Sonics is a pioneer of network-on-chip (NoC) technology and today offers SoC designers the largest portfolio of intelligent, on-chip communications solutions for home entertainment, wireless, networking and mobile devices. With a broad array of silicon-proven IP, Sonics helps designers eliminate memory bottlenecks associated with complex, high-speed SoC design, streamline and unify data flows and solve persistent network challenges in embedded systems with multiple cores. As the leading supplier of on-chip communications networks for the embedded market, Sonics has enabled its customers to ship more than 750 million units worldwide. Founded in 1996, Sonics is headquartered in Milpitas, Calif. with offices worldwide.

Translarity

Series A in 2005
Translarity is an innovator in the semiconductor wafer test industry, focused on the advanced probe card market. Headquartered in Silicon Valley, Translarity brings a disruptive change to the world of semiconductor test by offering a full-wafer test with low cost, high performance, and short cycle time. Translarity acquired BucklingBeam in 2017 to expand its offerings and deliver a full suite of probe card solutions, including full probe cards and vertical probe head solutions. Combined with the company’s advanced Space Translator™ space transformer technology, the company addresses the rapid state of acceleration in probe technologies. Translarity’s proven management team, backed by strong financial investors, recruited a dynamic team of top industry talent to address the unmet challenges in building the Wafer Translator™ technology. In creating the Translarity solution, the team developed a fertile innovation pipeline and a strong IP portfolio, with more than 45 patents already issued and more than 50 filed.

QuatRx Pharmaceuticals

Series D in 2005
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics.QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.
CICLON Semiconductor Device Corporation (pronounced see-clone) is a leader in the design, development, and sale of high-frequency, high-efficiency RF LDMOS and power MOSFET semiconductor solutions for high-performance information technology applications. The company was founded in 2004 and is based in Bethlehem, Pennsylvania. As of February 11, 2009, CICLON Semiconductor Device Corp. operates as a subsidiary of Texas Instruments Inc.

Zalicus

Series E in 2005
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010, the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.

Intellon Corporation

Series B in 2005
Intellon Corporation, a fabless semiconductor company, engages in the design, develop, manufacture, and marketing of integrated circuits (ICs) for powerline communications or high-speed communications over existing electrical wiring in the United States and internationally. They provides HomePlug-based ICs for home networking, networked entertainment, broadband over powerline access, ethernet-over-coax, smart grid management, and other commercial applications. The HomePlug-based ICs provide connectivity between broadband modems or routers and personal computers, set-top boxes, gaming consoles, and other electronic products within a home; and monitors electrical distribution system, as well as helps in distributing Internet, video-on-demand, and other services.

Apogee Photonics

Venture Round in 2005
As per the transaction announced on March 20, 2007, Apogee Photonics, Inc. was acquired by CyOptics, Inc. Apogee Photonics, Inc. engages in the design, development, and production integrated indium phosphide solutions for optical transmission systems that exceed the distance-extinction-power product for other optical semiconductor technologies. Its solutions include cooled, semi-cooled, and uncooled products for 10Gb/s and 40Gb/s transmission to several tier 1 system OEMs and module vendors. The company's products include thermistor-based temperature monitoring and modulator-based power monitoring products, electroabsorption-modulated lasers, and laser integrated modulators. Apogee Photonics, Inc. was formerly known as ASIP, Inc. Apogee Photonics, Inc. was founded in 2000 and is headquartered in Allentown, Pennsylvania with an additional office in New Jersey. The company also has sales locations in the United States, Canada, Europe, Israel, and Asia.

VeriWave

Series B in 2005
Testing with VeriWave ensures maximum performance for mobile networks, devices and applications in the real world. From development through deployment and beyond, VeriWave helps leading manufacturers, service providers and users measure, analyze and improve speed, quality, interoperability, compliance and other pivotal aspects of mobile performance.

Celator Pharmaceuticals

Series B in 2005
Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

Ventaira Pharmaceuticals

Series C in 2005
Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development of new inhalation products by utilizing its novel proprietary electrohydrodynamic (EHD) aerosolization and formulation technologies.

Optichron

Series B in 2005
Optichron®, Inc., a leader in nonlinear signal processing technology, designs and manufactures integrated circuits that enable significant improvements in system-level cost:performance for communications applications. Founded in January 2003, Optichron focuses on a significant technology challenge - a solution to the performance bottleneck caused by nonlinear distortion, a long-standing engineering barrier in many industries relying on signal processing technologies. Industry experts have long recognized nonlinear distortion as the principal roadblock to tapping the optimum performance potential in communications, data conversion and other signal processing applications because previous engineering approaches were inefficient, inadequate, cumbersome or expensive. There team has developed a proprietary mathematical approach to solving nonlinear distortion, from which we have derived a robust integrated circuit architecture that is the core of our linearization products. By efficiently eliminating all types of nonlinear distortion, our linearization technology significantly improves the parameters for overall system design and, through reduced component count and more efficient operation, lowers cost and power consumption. We embed our linearization technology in our practical, high-performance linearization products for applications such as wireless communications, software-defined radio, medical imaging, satellite communications, radar, infrared imaging, and test and measurement instrumentation.

T-Networks

Series C in 2005
Electronic Components, Modulators available from T-Networks Inc. based in Allentown, PA.

Blaze Public Relations

Venture Round in 2005
The Blaze Company provides marketing communications services to travel, retail, entertainment, magazines, institutes, and financial services industries. The company offers press conference, media placement analysis, direct mail, event marketing, public relations, online research, and strategic corporate counsel. Its clientele includes Seagrams, Denis Austin, Cruise & Resort Magazine, Hollywood Marketing Corporation, Cafй Med, Tomy America Inc., and Glad Bags. The company is based in Venice, California. As of 05/12/2004, The Blaze Company is a subsidiary of Davies.

QuatRx Pharmaceuticals

Series D in 2004
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics.QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

Sopherion Therapeutics

Series B in 2004
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company headquartered in Princeton, New Jersey with offices in Cheshire, Connecticut, Estero, Florida and an operating subsidiary, Sopherion Therapeutics Canada, in Toronto, Canada. Sopherion Therapeutics LLC is a specialty biopharmaceutical company with an exclusive licensing agreement with Zeneus Pharma Ltd., now Cephalon, Inc., for the commercialization of Myocet™ (a liposome-encapsulated doxorubicin-citrate complex) in the United States and Canada. Sopherion’s current business focus is the execution of a Phase III, global, randomized, registration trial for first line therapy of invasive, metastatic breast cancer and the development and commercialization of Sopherion’s lead agent, Myocet™. Myocet is being investigated in an FDA agreed upon registration trial in combination with two other drugs, Herceptin® (Trastuzumab) and Taxol (Paclitaxel) vs. Herceptin® and Taxol alone, the current standard of care for first line HER-2-overexpressing metastatic breast cancer. Myocet™, a liposome-encapsulated doxorubicin with reduced cardiotoxicity, is a nanotechnology product that localizes into tumor vasculature and in contrast to parental doxorubicin avoids homing to the heart. This 363 patient global trial in twelve countries has as of 03/06/09 been fully recruited. Unblinding is anticipated by the summer of 2010 with NDA submission for full approval following within 6 months. Myocet® is already a registered drug in Canada, where Sopherion has commercial rights and in Europe where Cephalon has commercial rights for use in first line metastatic breast cancer in combination with cyclophosphamide.; Their Phase III trial is based on a Phase II trial, supported by Roche, which gave a 96% response rate and two and a half year median progression free survival for patients with metastatic breast cancer.

AirWalk Communications

Series A in 2004
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.

Sonics

Series C in 2004
Sonics is a pioneer of network-on-chip (NoC) technology and today offers SoC designers the largest portfolio of intelligent, on-chip communications solutions for home entertainment, wireless, networking and mobile devices. With a broad array of silicon-proven IP, Sonics helps designers eliminate memory bottlenecks associated with complex, high-speed SoC design, streamline and unify data flows and solve persistent network challenges in embedded systems with multiple cores. As the leading supplier of on-chip communications networks for the embedded market, Sonics has enabled its customers to ship more than 750 million units worldwide. Founded in 1996, Sonics is headquartered in Milpitas, Calif. with offices worldwide.

Atrenta

Series C in 2004
Atrenta’s SpyGlass Predictive Analysis software platform significantly improves design efficiency for the world’s leading semiconductor and consumer electronics companies. Patented solutions provide early design insight into the demanding performance, power and area requirements of the complex system on chips (SoCs) fueling today’s consumer electronics revolution. More than two hundred companies and thousands of design engineers worldwide rely on SpyGlass to reduce risk and cost before traditional EDA tools are deployed. SpyGlass functions like an interactive guidance system for design engineers and managers, finding the fastest and least expensive path to implementation for complex SoCs. SpyGlass from Atrenta: Insight. Efficiency. Confidence.

Ikanos

Series E in 2004
Ikanos develops robust, high performance semiconductor and software products. Their advanced communications processors, broadband DSL and other devices power access infrastructure and customer premises equipment for many of the world’s leading network equipment manufacturers and telecommunications service providers. With more than 330 million ports shipped to date, they are enabling the cost-effective delivery of triple- and quadruple-play services to and throughout homes and offices around the world.

Intellon Corporation

Venture Round in 2004
Intellon Corporation, a fabless semiconductor company, engages in the design, develop, manufacture, and marketing of integrated circuits (ICs) for powerline communications or high-speed communications over existing electrical wiring in the United States and internationally. They provides HomePlug-based ICs for home networking, networked entertainment, broadband over powerline access, ethernet-over-coax, smart grid management, and other commercial applications. The HomePlug-based ICs provide connectivity between broadband modems or routers and personal computers, set-top boxes, gaming consoles, and other electronic products within a home; and monitors electrical distribution system, as well as helps in distributing Internet, video-on-demand, and other services.

CombinatoRx

Series C in 2004
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.

CorrectNet

Series B in 2004
CorrectNet is the market leader in managed service-based information delivery and client reporting for many of the world's largest investment management firms. Founded in 1997, CorrectNet provides infrastructure, operations and people to manage the aggregation, enrichment, quality assurance and formatting of complex investment data, delivered through rich reporting web portals to investors, portfolio managers, operations teams and executives. CorrectNet has demonstrated a unique ability to satisfy the toughest transparency and reporting standards of leading hedge funds, funds of funds, fund administrators and prime brokers.

Zalicus

Series D in 2004
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010, the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.

blaze

Series A in 2004
Blaze is the safest, easiest, and most fun way to play online games.

Netrake

Series D in 2004
Netrake Corporation provides voice and multimedia solutions across Internet protocol (IP) networks to wireline, wireless, cable, and fixed/mobile operators. The company offers session border controllers that enable connectivity, policies, and security for VoIP and video sessions when traversing IP-to-IP networks; security gateways to enable secure real-time sessions across Wi-Fi, broadband, and wireless networks in fixed mobile convergence deployments. Its products support carrier-to-carrier peering, residential/Internet service providers, and business VoIP access services. The company was founded in 2000 and is based in Plano, Texas. As of August 14, 2006, Netrake Corporation operates as a subsidiary of AudioCodes, Inc.

VeriWave

Series A in 2003
Testing with VeriWave ensures maximum performance for mobile networks, devices and applications in the real world. From development through deployment and beyond, VeriWave helps leading manufacturers, service providers and users measure, analyze and improve speed, quality, interoperability, compliance and other pivotal aspects of mobile performance.

AirWalk Communications

Venture Round in 2003
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.

QuatRx Pharmaceuticals

Series C in 2003
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics.QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

AirWalk Communications

Series A in 2003
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.

Atrenta

Series B in 2003
Atrenta’s SpyGlass Predictive Analysis software platform significantly improves design efficiency for the world’s leading semiconductor and consumer electronics companies. Patented solutions provide early design insight into the demanding performance, power and area requirements of the complex system on chips (SoCs) fueling today’s consumer electronics revolution. More than two hundred companies and thousands of design engineers worldwide rely on SpyGlass to reduce risk and cost before traditional EDA tools are deployed. SpyGlass functions like an interactive guidance system for design engineers and managers, finding the fastest and least expensive path to implementation for complex SoCs. SpyGlass from Atrenta: Insight. Efficiency. Confidence.

Immunicon

Series F in 2003
They are developing and commercializing proprietary cell-based research and diagnostic products with an initial focus on cancer. They believe that their current and future products can provide significant clinical benefits by giving physicians better information to understand, diagnose, treat and monitor cancer. They design their products to provide physicians and scientists with clinically meaningful information earlier than current diagnostic methods. Their technologies, which they brand as CellTracks, can identify, count and characterize the presence and quantity of a small number of tumor cells present in a blood sample. Their collaborator, Veridex, LLC, or Veridex, a Johnson & Johnson company, submitted a pre-market notification, or 510(k), to the US Food and Drug Administration, or FDA, in May 2003 for use of the CellSearch Epithelial Cell Kit in the management of metastatic breast cancer. They expect that the CellSearch Epithelial Cell Kit will be the initial product launched by Veridex based on their technologies. They believe that their products and underlying technology platforms have other applications in cancer diagnostics, in the development of cancer drugs and in cancer research. In addition, they believe that their proprietary technologies may have applications in other fields of medicine, such as cardiovascular and infectious diseases.

Ikanos

Series D in 2003
Ikanos develops robust, high performance semiconductor and software products. Their advanced communications processors, broadband DSL and other devices power access infrastructure and customer premises equipment for many of the world’s leading network equipment manufacturers and telecommunications service providers. With more than 330 million ports shipped to date, they are enabling the cost-effective delivery of triple- and quadruple-play services to and throughout homes and offices around the world.

eRealty.com

Series E in 2003
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.

QuatRx Pharmaceuticals

Series C in 2003
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics.QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

Sopherion Therapeutics

Series A in 2003
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company headquartered in Princeton, New Jersey with offices in Cheshire, Connecticut, Estero, Florida and an operating subsidiary, Sopherion Therapeutics Canada, in Toronto, Canada. Sopherion Therapeutics LLC is a specialty biopharmaceutical company with an exclusive licensing agreement with Zeneus Pharma Ltd., now Cephalon, Inc., for the commercialization of Myocet™ (a liposome-encapsulated doxorubicin-citrate complex) in the United States and Canada. Sopherion’s current business focus is the execution of a Phase III, global, randomized, registration trial for first line therapy of invasive, metastatic breast cancer and the development and commercialization of Sopherion’s lead agent, Myocet™. Myocet is being investigated in an FDA agreed upon registration trial in combination with two other drugs, Herceptin® (Trastuzumab) and Taxol (Paclitaxel) vs. Herceptin® and Taxol alone, the current standard of care for first line HER-2-overexpressing metastatic breast cancer. Myocet™, a liposome-encapsulated doxorubicin with reduced cardiotoxicity, is a nanotechnology product that localizes into tumor vasculature and in contrast to parental doxorubicin avoids homing to the heart. This 363 patient global trial in twelve countries has as of 03/06/09 been fully recruited. Unblinding is anticipated by the summer of 2010 with NDA submission for full approval following within 6 months. Myocet® is already a registered drug in Canada, where Sopherion has commercial rights and in Europe where Cephalon has commercial rights for use in first line metastatic breast cancer in combination with cyclophosphamide.; Their Phase III trial is based on a Phase II trial, supported by Roche, which gave a 96% response rate and two and a half year median progression free survival for patients with metastatic breast cancer.

BayPackets

Series C in 2003
BayPackets' software enables wireless, wireline and cable operators to rapidly bundle and deliver enhanced voice and data services tailored to the needs of their business and consumer customers. Local, long-distance and broadband service providers rely on BayPackets' solutions to profitably expand their market share by efficiently operating new and existing network infrastructure via a single point.

Ventaira Pharmaceuticals

Series B in 2003
Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development of new inhalation products by utilizing its novel proprietary electrohydrodynamic (EHD) aerosolization and formulation technologies.

VIEO

Series B in 2003
VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.

eRealty.com

Series D in 2002
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.

Netrake

Series C in 2002
Netrake Corporation provides voice and multimedia solutions across Internet protocol (IP) networks to wireline, wireless, cable, and fixed/mobile operators. The company offers session border controllers that enable connectivity, policies, and security for VoIP and video sessions when traversing IP-to-IP networks; security gateways to enable secure real-time sessions across Wi-Fi, broadband, and wireless networks in fixed mobile convergence deployments. Its products support carrier-to-carrier peering, residential/Internet service providers, and business VoIP access services. The company was founded in 2000 and is based in Plano, Texas. As of August 14, 2006, Netrake Corporation operates as a subsidiary of AudioCodes, Inc.

Zalicus

Series C in 2002
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010, the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.

Participate Systems

Series D in 2002
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.

Sonics

Series C in 2002
Sonics is a pioneer of network-on-chip (NoC) technology and today offers SoC designers the largest portfolio of intelligent, on-chip communications solutions for home entertainment, wireless, networking and mobile devices. With a broad array of silicon-proven IP, Sonics helps designers eliminate memory bottlenecks associated with complex, high-speed SoC design, streamline and unify data flows and solve persistent network challenges in embedded systems with multiple cores. As the leading supplier of on-chip communications networks for the embedded market, Sonics has enabled its customers to ship more than 750 million units worldwide. Founded in 1996, Sonics is headquartered in Milpitas, Calif. with offices worldwide.

BroadCloud Communications

Series B in 2002
BroadCloud Communications is a web-based application service provider (ASP) of wireless Internet transmission services.

Celarix

Private Equity Round in 2002
Celarix offers simply the best way to manage every aspect of your logistics operation. No longer do you have to piece together disparate information and fill in the gaps yourself. Whether you're a shipper or a transportation service provider, you owe it to yourself and your company to find out exactly what we have in store for you.

Sabeus Photonics

Series C in 2001
Sabeus Photonics optical devices and expand manufacturing facilities. Sabeus supplies optical communications components.

Coriolis Networks

Series C in 2001
Coriolis Networks, headquartered in Boxborough, Mass., began in mid 1999 with a mission to develop a comprehensive approach to the needs of carriers for reliable and scalable optical network solutions. From the beginning, Coriolis Networks realized that success in this market would be based on providing customers with a solution that was compatible with existing SONET network architectures but dramatically improved on the data service delivery capability with new lower price points. Coriolis' target market is the network service provider community on a global basis. Our target customers include competitive and incumbent local exchange carriers, Internet service providers, and wholesale carriers that are building out their fiber-optic facilities to meet their end-user demands for more high-speed data services as well as traditional metro services.

Circadiant Systems, Inc

Series B in 2001
Circadiant Systems, Inc. manufactures optical test systems for optical component developers, network equipment manufacturers, and telecom service providers. The company offers electrical/optical compliance system for module, host card and IC testing applications; HYDRA LRM-M that solves the issues of calibration, instrument drift, and system-to-system correlation that can normally slow product release; HYDRA MTS that solves the issues of calibration, instrument drift, and system-to-system correlation that normally slow design cycles; and optical standard tester-ST that accurately generates various optical impairments, including optical signal-to-noise ratio, as well as automates performance and conformance testing of 10 Gb/s devices and systems. It also provides OSS-RW that offers creation of different optical impairments for testing performance of 10 Gb/s devices; OST-SRS provides stressed receiver sensitivity conformance testing of 10 gigabit Ethernet devices; and A3318 that enables the OST to make stressed eye measurements. In addition, it offers long reach multimode solutions that offer a scant 100m coverage with conventional 850nm optics; protocol layer testing; electronic dispersion compensation testing; and system level testing solutions.

eRealty.com

Series B in 2001
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.

Matrix

Series A in 2001
Provides services to measure Internet performance.

B-there.com

Venture Round in 2001
B-there.com provides online event management solutions for the meeting, trade show, and convention industries. It is based in Westport, Connecticut.

Planalytics (B2B)

Venture Round in 2001
Planalytics is the global leader in Business Weather Intelligence helping companies effectively assess and proactively address how the weather impacts their business. Their analytics, online tools and services help companies measure and manage the impact of weather throughout all facets of an organization. They are the pioneers of climate-driven solutions, making it possible for companies to use weather as a metric in their everyday business practices. Planalytics was founded in 1996. Throughout their history, Planalytics has evolved from a data provider to a consulting firm, and since 2004, a SAAS platform. Through emerging cloud technologies, their analytics are now available faster and more efficiently than ever before. In 2001, Planalytics expanded their global footprint by opening an office in the United Kingdom. Today, they serve all of Europe, Mexico and Latin America. As their client base has grown, so have they Their experience over the years in a multitude of industries and areas within an organization has led us to develop the capabilities to weatherize an entire business.

Matrix.Net

Series A in 2001
Incorporated in 1990, MIDS is a pioneer of electronic commerce. MIDS started Matrix IQ the first for-pay non-academic periodical distributed over the Internet drew the first maps of the Internet as a whole, conducted the first demographic survey of the Internet, MIDS Internet Average and first monitored the Internet as a whole. MIDS is known as the granddaddy of Internet monitoring service providers. Since 1993 MIDS has been collecting a continuous stream of data in Their Internet Weather Report MIDS Internet Weather Report. Since 1995, MIDS has been displaying IWR data on the web as animated GIF and Java maps of current conditions in the Internet. MIDS makes geographical maps of Internet hosts, hosts per capita, latencies, links, and other aspects of the Internet available.

VIEO

Series A in 2001
VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.

IPnetwork

Series B in 2000
IPnetwork provides foreign advertising solutions via TV, radio, and internet delivery platforms.

Ascentive

Venture Round in 2000
We are an eclectic and energetic group of software developers, designers, marketers, media mavens, sales superstars and customer service professionals who work together to create innovative software products. Ascentiveâ€:tm:s mission statement is to develop easy-to-use software for consumers and businesses for solving everyday PC problems, backed by top-notch customer support and service. With a dozen products, Ascentive is a market leader in corporate and consumer software and has received accolades from media organizations like The Wall Street Journal, Newsweek, Forbes, Tech TV and NBC. Ascentive products and services are used by hundreds of thousands of people and businesses, with registered customers in 55 countries.

Isochron Data

Series A in 2000
Isochron Data Corporation (Isochron) is the leading application service provider of enterprise information solutions and wireless devices for customers seeking to communicate with their distributed field assets. Isochron's solutions connect people, devices, and enterprise systems to provide customers with vital information to improve their top and bottom lines. With Isochron's solutions, managers have direct control over their field assets and immediate access to timely, accurate, and actionable information to better manage their businesses.

Factory Logic

Series A in 2000
Factory Logic, Inc. provides factory management solutions. The company develops Streamline Lean Factory Management System, an operational management software solution that provides factory personnel with the integrated tools to design, operate, and improve lean manufacturing facilities. Its Lean Operations suite supports an integrated approach that directly links production to customer demand, as well as maintains stability required for factory and supply chain operations. The company also undertakes consulting projects. It serves automotive, electronics, industrial equipment, and aerospace industries. The company was formerly known as Scintellect Systems, Inc. The company was founded in 1993 and is based in Austin, Texas. As of December 18, 2006, Factory Logic, Inc. operates as a subsidiary of SAP AG.

Ineto

Series B in 2000
Ineto operates as a new customer communications service provider.

Highway To Health

Venture Round in 2000
Highway to Health, (HTH) applies its dynamic Internet expertise to bring innovative online healthcare services and insurance to international travel, study, and commerce. Each year thousands of leisure and business travelers as well as international students and scholars protect themselves, their families, and their travel plans with HTH. Their programs combine comprehensive, competitively priced insurance products with critical travel health information, known as CityHealthProfiles, and online medical assistance services available through HTH TravelersClub. Members enjoy access to their community of pre-selected, contracted physicians in over 100 countries, and their interactive translation guides for brand-name pharmaceuticals and common medical terms and phrases.

Powered

Series B in 2000
Powered is a social marketing consultancy that helps companies become more engaged in an increasingly digital, connected and social world. Utilizing a proven set of effective practices and technologies, Powered helps companies navigate the entire social marketing spectrum, providing social marketing: strategy, planning, program development and execution, program management, content marketing, blogger outreach, influencer activation, advocacy programs, branded communities, and branded events.

WebVision

Series C in 2000
Webvisions provided shared hosting, dedicated server and co-location services to small and midsized businesses throughout Asia.

Go-Active

Venture Round in 2000
Go-Active is a new online application service provider for the health club industry

Utility Associates

Series B in 2000
Utility Associates, Inc. offers mobile resource management solutions to command and control field operations. It offers AVaiL, which delivers a mobile operations command and control service that provides a view of the current location and status of mobile resources layered with data from various business systems, such as GIS, customer, and outage management yielding unparalleled awareness of mobile operations; AVaiL-Navigator, which provides an on board navigation system; AVaiL Tablet, which delivers various levels of mobile computing functionalities; AVaiL RFID, which delivers information on the location and status of various mobile resources; AVaiL Diagnostics, which delivers vehicle diagnostic information to AVaiL command and control; AVaiL Cell, which is downloaded to cell-phones; PadWORKS, a work management system for the utility industry; AVaiL Boost, which maintains wireless connectivity in geographic areas; and OnComm Rocket, which enables enterprises to track the location and status of various mobile assets, such as toolboxes, backhoes, personnel, and vehicles.

ibooks.com

Series B in 2000
ibooks.com is a mobile-based application that enables its users to download and read books on their iPhone, iPod touch, or iPad.

BroadCloud Communications

Series A in 2000
BroadCloud Communications is a web-based application service provider (ASP) of wireless Internet transmission services.

B-there.com

Venture Round in 2000
B-there.com provides online event management solutions for the meeting, trade show, and convention industries. It is based in Westport, Connecticut.

Participate Systems

Series B in 2000
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.